Table 1. Demographic and preoperative clinical data.
| Groups* | All patients | TAVI | SAVR | |||||
|---|---|---|---|---|---|---|---|---|
| COV(–) (n=102) | COV(+) (n=56) | COV(–) (n=50) | COV(+) (n=37) | COV(–) (n=52) | COV(+) (n=19) | |||
| Age (years) | 71.8±9.7 | 71.4±10.2 | 78.2±7.5 | 75.6±6.1 | 66.3±9.2 | 63.5±13.2 | ||
| >75 years | 52 (51.0) | 28 (50.0) | 38 (76.0) | 27 (73.0) | 14 (26.9) | 1 (5.3)# | ||
| Gender (F/M) | 59 (57.8)/43 (42.2) | 32 (57.1)/24 (42.9) | 29 (58.0)/21 (42.0) | 20 (54.1)/17 (45.9) | 30 (57.7)/22 (42.3) | 12 (63.2)/7 (36.8) | ||
| NYHA III/IV | 21 (20.6) | 23 (41.1)# | 13 (26.0) | 13 (35.1) | 8 (15.4) | 10 (52.6)# | ||
| Obesity1 | 21 (20.6) | 13 (23.2) | 14 (28.0) | 10 (27.0) | 7 (13.5) | 3 (15.8) | ||
| AH | 73 (71.6) | 44 (78.6) | 43 (86.0) | 31 (83.8) | 30 (57.7) | 13 (68.4) | ||
| HL | 26 (25.5) | 23 (41.1)# | 13 (26.0) | 13 (25.0) | 13 (25.0) | 10 (52.6)# | ||
| COPD | 6 (5.9) | 7 (12.5) | 3 (6.0) | 6 (16.2)# | 3 (5.8) | 1 (5.3) | ||
| DM | 38 (37.3) | 24 (42.9) | 21 (42.0) | 17 (45.9) | 17 (32.7) | 7 (37) | ||
| PVD2 | 25 (24.5) | 18 (32.1) | 15 (30.0) | 15 (40.5) | 10 (19.2) | 3 (15.8) | ||
| TIA/CVA | 11 (10.8) | 2 (3.6) | 9 (18.0) | 2 (5.4) | 2 (3.8) | 0 (0.0) | ||
| CAD | 44 (43.1) | 29 (51.8) | 25 (50.0) | 16 (43.2) | 19 (36.5) | 13 (68.4)# | ||
| Prev. MI | 19 (18.6) | 13 (23.2) | 14 (28.0) | 9 (24.3) | 5 (9.6) | 4 (21.1) | ||
| PCI in hist. | 25 (24.5) | 19 (33.9) | 19 (38.0) | 14 (37.8) | 6 (11.5) | 5 (26.3) | ||
| RF3 | 31 (30.4) | 27 (48.2)# | 28 (56.0) | 24 (64.9) | 3 (5.8) | 3 (15.8) | ||
| ES II4 (%) | 1.70 (1.21–2.99) | 2.68# (1.72–3.56) | 2.80 (1.78–4.66) | 3.09 (2.04–5.30) | 1.21 (0.93–1.59) | 1.84# (1.11–3.35) | ||
*, continuous data are expressed as the means ± SD or the medians with interquartile ranges (25th–75th percentile) while categorical as the numbers (n) with percentages (%); #, P<0.05 COV(–) vs. COV(+) groups; bolded data are of statistical significance. 1, defined if BMI exceeded 30 kg/m2; 2, if glomerular filtration rate (eGFR) was below 60 mL/kg/1.73 m2; 3, it refers only to the arteries of the lower extremities; 4, logistic EuroSCORE II stratifies risk of early mortality (up to 30 days following intervention). TAVI, transcatheter aortic valve implantation; SAVR, surgical aortic valve replacement; COV, patients treated before (–) or during COVID-19 (+) pandemic; F, female; M, male; NYHA, New York Heart Association class; AH, arterial hypertension; HL, hiperlipidemia; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; PVD, peripheral vascular disease; TIA, transient ischemic attack; CVA, cerebrovascular accident (brain stroke); CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; RF, renal failure; ES, EuroSCORE; SD, standard deviation; BMI, body mass index.